Founders Financial Alliance, LLC Gsk PLC Transaction History

Founders Financial Alliance, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $67,868 - $77,100	-1,614 Reduced 22.93%	5,426 $236,000
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $38 - $45	1 Added 0.01%	7,040 $310,000
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $10,486 - $12,243	306 Added 4.54%	7,039 $266,000
Q4 2020 Feb 04, 2021	BUY	$34.07 - $39.94 $18,738 - $21,967	550 Added 8.9%	6,733 $246,000
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $235,634 - $265,807	6,183 New	6,183 $230,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Founders Financial Alliance, LLC, based on Form 13F filings with the SEC.

Stay updated on Founders Financial Alliance, LLC with notifications on news.